These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34334192)
1. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro. Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192 [No Abstract] [Full Text] [Related]
2. Protamine dosing--the quandary continues. Hall RI Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018 [No Abstract] [Full Text] [Related]
4. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211 [TBL] [Abstract][Full Text] [Related]
5. Interaction of heparin and protamine in presence of overdosage: in vitro study. Hanke AA; Severloh I; Flöricke F; Weber CF; Lang T Asian Cardiovasc Thorac Ann; 2021 Jan; 29(1):5-9. PubMed ID: 32854516 [TBL] [Abstract][Full Text] [Related]
6. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770 [TBL] [Abstract][Full Text] [Related]
8. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery. Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380 [TBL] [Abstract][Full Text] [Related]
9. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778 [TBL] [Abstract][Full Text] [Related]
10. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery. Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199 [TBL] [Abstract][Full Text] [Related]
11. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis. Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158 [TBL] [Abstract][Full Text] [Related]
12. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient. Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588 [TBL] [Abstract][Full Text] [Related]
13. Heparin neutralization by recombinant platelet factor 4 and protamine. Levy JH; Cormack JG; Morales A Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278 [TBL] [Abstract][Full Text] [Related]
14. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system. El Rouby S; Rinehart K; Zucker ML; LaDuca FM J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423 [TBL] [Abstract][Full Text] [Related]
15. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705 [TBL] [Abstract][Full Text] [Related]
16. Validation of viscoelastic coagulation tests during cardiopulmonary bypass. Ortmann E; Rubino A; Altemimi B; Collier T; Besser MW; Klein AA J Thromb Haemost; 2015 Jul; 13(7):1207-16. PubMed ID: 25903995 [TBL] [Abstract][Full Text] [Related]
17. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass. Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140 [TBL] [Abstract][Full Text] [Related]
18. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Mittermayr M; Margreiter J; Velik-Salchner C; Klingler A; Streif W; Fries D; Innerhofer P Br J Anaesth; 2005 Sep; 95(3):310-6. PubMed ID: 16024582 [TBL] [Abstract][Full Text] [Related]
19. A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery. Heres EK; Horrow JC; Gravlee GP; Tardiff BE; Luber J; Schneider J; Barragry T; Broughton R Anesth Analg; 2001 Dec; 93(6):1446-52, table of contents. PubMed ID: 11726421 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Boer C; Meesters MI; Veerhoek D; Vonk ABA Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]